Insider Trading History of Peyromaure De Bord Alison

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Peyromaure De Bord Alison since 2007. The trader's CIK number is 1341637. At the time of the last reporting, Peyromaure De Bord Alison was the Director of Aegerion Pharmaceuticals, Inc.. (stock ticker symbol AEGR). Also see all insider trading activities at Aegerion Pharmaceuticals, Inc..

Note that in the past Peyromaure de Bord Alison also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aegerion Pharmaceuticals, Inc. (AEGR) by Peyromaure De Bord Alison

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 AEGR 0 $0 200,733 $3,679,056 0 $0
2011 AEGR 9,700 $120,703 0 $0 0 $0
2010 AEGR 315,789 $2,999,995 0 $0 0 $0

Yearly summary of insider trading at Insulet Corp (PODD) by Peyromaure De Bord Alison

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 PODD 0 $0 511,052 $0 0 $0


Insider trading activities at 2 companies by Peyromaure De Bord Alison:

1. Aegerion Pharmaceuticals, Inc. (AEGR)

2. Insulet Corp (PODD)

Table 1. Insider trading of Aegerion Pharmaceuticals, Inc. (AEGR) by Peyromaure De Bord Alison

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-10-16 AEGR Sale 140,000 18.67 2,613,800
2012-10-15 AEGR Sale 60,733 17.54 1,065,256
2011-08-09 AEGR Buy 5,500 12.45 68,497
2011-08-08 AEGR Buy 4,200 12.43 52,206
2010-10-27 AEGR Buy 315,789 9.50 2,999,995

Table 2. Insider trading of Insulet Corp (PODD) by Peyromaure De Bord Alison

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-11-13 PODD Sale 511,052 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Peyromaure De Bord Alison (Director of Aegerion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.